119 related articles for article (PubMed ID: 9426744)
1. Bicalutamide-associated fulminant hepatic failure.
Chodak GW
Urology; 1997 Dec; 50(6):1027. PubMed ID: 9426744
[No Abstract] [Full Text] [Related]
2. Fulminant hepatic failure associated with bicalutamide.
Dawson LA; Chow E; Morton G
Urology; 1997 Feb; 49(2):283-4. PubMed ID: 9037299
[TBL] [Abstract][Full Text] [Related]
3. Fulminant hepatic failure associated with bicalutamide.
Schellhammer PF
Urology; 1997 Nov; 50(5):827. PubMed ID: 9372905
[No Abstract] [Full Text] [Related]
4. Bicalutamide-associated fulminant hepatotoxicity.
O'Bryant CL; Flaig TW; Utz KJ
Pharmacotherapy; 2008 Aug; 28(8):1071-5. PubMed ID: 18657023
[TBL] [Abstract][Full Text] [Related]
5. Interstitial pneumonitis following bicalutamide treatment for prostate cancer.
McCaffrey JA; Scher HI
J Urol; 1998 Jul; 160(1):131. PubMed ID: 9628626
[No Abstract] [Full Text] [Related]
6. Fulminant liver failure associated with flutamide therapy for hirsutism.
Andrade RJ; Lucena MI; Fernández MC; Suárez F; Montero JL; Fraga E; Hidalgo F
Lancet; 1999 Mar; 353(9157):983. PubMed ID: 10459914
[No Abstract] [Full Text] [Related]
7. The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.
Nuttall MC; Harris JP; Dawkins GP
BJU Int; 2007 Feb; 99(2):243-4. PubMed ID: 17313420
[No Abstract] [Full Text] [Related]
8. A case of male breast cancer in association with bicalutamide-induced gynaecomastia.
Chianakwalam CI; McCahy P; Griffiths NJ
Breast; 2005 Apr; 14(2):163-4. PubMed ID: 15767188
[No Abstract] [Full Text] [Related]
9. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
Hara T; Miyazaki J; Araki H; Yamaoka M; Kanzaki N; Kusaka M; Miyamoto M
Cancer Res; 2003 Jan; 63(1):149-53. PubMed ID: 12517791
[TBL] [Abstract][Full Text] [Related]
10. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
Van Poppel H
Eur Urol; 2007 Jul; 52(1):115. PubMed ID: 17270341
[No Abstract] [Full Text] [Related]
11. [Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].
Abdah-Bortnyak R; Bernstein Z; Ramon N; Zalman D; Shnaider J; Kuten A
Harefuah; 2007 Feb; 146(2):126-8, 164-5. PubMed ID: 17352282
[TBL] [Abstract][Full Text] [Related]
12. Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade.
Tanvetyanon T; Choudhury AM
J Urol; 2004 Apr; 171(4):1627. PubMed ID: 15017238
[No Abstract] [Full Text] [Related]
13. Pneumonitis and non steroidal antiandrogens.
Prescrire Int; 2003 Aug; 12(66):141. PubMed ID: 12908492
[TBL] [Abstract][Full Text] [Related]
14. Bicalutamide.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17458049
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
Manso G; Thole Z; Salgueiro E; Revuelta P; Hidalgo A
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):253-9. PubMed ID: 16294367
[TBL] [Abstract][Full Text] [Related]
16. Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?
Ramsey S; Veenstra D; Clarke L; Gandhi S; Hirsch M; Penson D
Urology; 2005 Oct; 66(4):835-9. PubMed ID: 16230148
[TBL] [Abstract][Full Text] [Related]
17. [The role of bicalutamide in the treatment of prostate cancer].
Stav SY; Segal G
Harefuah; 2002 Apr; 141(4):379-83, 408, 407. PubMed ID: 12017896
[TBL] [Abstract][Full Text] [Related]
18. Side-effects of treatments for locally advanced prostate cancer.
O'Connor KM; Fitzpatrick JM
BJU Int; 2006 Jan; 97(1):22-8. PubMed ID: 16336322
[No Abstract] [Full Text] [Related]
19. Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity.
Kashimshetty R; Desai VG; Kale VM; Lee T; Moland CL; Branham WS; New LS; Chan EC; Younis H; Boelsterli UA
Toxicol Appl Pharmacol; 2009 Jul; 238(2):150-9. PubMed ID: 19442681
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer tissue is masked by bicalutamide: a case report.
Ellinger J; Bastian PJ; Biermann K; Schmidt ME; Textor J; Bollmann D; Zhou H; Müller SC
Eur J Med Res; 2007 May; 12(5):212-5. PubMed ID: 17513193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
